Paul P. Tak

Active 1994–2025

Also published as
Paul P Tak · Paul-P Tak
233
Papers
55,480
Citations
123
h-index
228
i10-index

Citations

Citations per year for Paul P. Tak1987: 3 citations1988: 1 citations1990: 1 citations1992: 3 citations1995: 1 citations1996: 3 citations1997: 24 citations1998: 37 citations1999: 79 citations2000: 111 citations2001: 115 citations2002: 160 citations2003: 154 citations2004: 210 citations2005: 205 citations2006: 168 citations2007: 223 citations2008: 244 citations2009: 347 citations2010: 501 citations2011: 567 citations2012: 612 citations2013: 630 citations2014: 610 citations2015: 709 citations2016: 671 citations2017: 759 citations2018: 623 citations2019: 2,064 citations2020: 1,942 citations2021: 1,805 citations2022: 1,403 citations2023: 906 citations2024: 1,370 citations2025: 706 citations2026: 17 citations1989: no citations, so this year is not shown1991: no citations, so this year is not shown1993–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,671 citing papers, 19.9% of this breakdownChina: 2,447 citing papers, 10.4% of this breakdownUnited Kingdom: 2,024 citing papers, 8.6% of this breakdownNetherlands: 1,284 citing papers, 5.5% of this breakdownGermany: 1,248 citing papers, 5.3% of this breakdownItaly: 1,044 citing papers, 4.5% of this breakdownFrance: 841 citing papers, 3.6% of this breakdownJapan: 825 citing papers, 3.5% of this breakdownCanada: 717 citing papers, 3.1% of this breakdownSpain: 612 citing papers, 2.6% of this breakdownSweden: 600 citing papers, 2.6% of this breakdownAustralia: 599 citing papers, 2.6% of this breakdown
0%19.9%Other 27.8%

Fields

  • Medicine53.4%
  • Biochemistry, Genetics and Molecular Biology22.1%
  • Immunology and Microbiology14.5%
  • Neuroscience5.2%
  • Agricultural and Biological Sciences1%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Other3%

Topics

  • Rheumatoid Arthritis Research and Therapies9.7%
  • Systemic Lupus Erythematosus Research3.8%
  • Spondyloarthritis Studies and Treatments2.9%
  • Autoimmune and Inflammatory Disorders Research2.4%
  • T-cell and B-cell Immunology2.3%
  • Psoriasis: Treatment and Pathogenesis2%
  • Other76.9%

Coauthors

All papers

Open in search
  1. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul P. Tak, Katherine S. Upchurch, Jiří Vencovský, Frederick Wolfe, Gillian Hawker - Arthritis & Rheumatism 2010 cited by 9,560

  2. NF-κB: a key role in inflammatory diseases

    Authors: , - Journal of Clinical Investigation 2001 cited by 3,885

  3. Genetics of rheumatoid arthritis contributes to biology and drug discovery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xuezhong Zhou, Namrata Gupta, Daniel B. Mirel, Eli A. Stahl, Dorothée Diogo, Jing Cui, Katherine P. Liao, Michael H. Guo, Keiko Myouzen, Takahisa Kawaguchi, Marieke J. H. Coenen, Piet L. C. M. van Riel, Mart A F J van de Laar, Henk‐Jan Guchelaar, T. Huizinga, Philippe Dieudé, Xavier Mariette, S. Louis Bridges, Alexandra Zhernakova, René E. M. Toes, Paul P. Tak, Corinne Miceli‐Richard, So‐Young Bang, Hye‐Soon Lee, Javier Martı́n, Miguel Á. González‐Gay, Luis Rodríguez‐Rodríguez, Solbritt Rantapää‐Dahlqvist, Lisbeth Ärlestig, Hyon K. Choi, Yoichiro Kamatani, Pilar Galán, Mark Lathrop, Steve Eyre, John Bowes, Anne Barton, Niek de Vries, Larry W. Moreland, Lindsey A. Criswell, Elizabeth W. Karlson, Atsuo Taniguchi, Ryo Yamada, Michiaki Kubo, Jun S. Liu, Sang‐Cheol Bae, Jane Worthington, Leonid Padyukov, Lars Klareskog, Peter K. Gregersen, Soumya Raychaudhuri, Barbara E. Stranger, Philip L. De Jager, Lude Franke, Peter M. Visscher, Matthew A. Brown, Hisashi Yamanaka, Tsuneyo Mimori, Atsushi Takahashi, Huji Xu, Timothy W. Behrens, Katherine Siminovitch, Shigeki Momohara, Fumihiko Matsuda, Kazuhiko Yamamoto, Robert M. Plenge - Nature 2013 cited by 2,499

  4. Clinical trial links oncolytic immunoactivation to survival in glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott J. Rodig, Patrick Y. Wen, Eudocia Q. Lee, Lakshmi Nayak, Ugonma Chukwueke, L. Nicolas Gonzalez Castro, Sydney Dumont, Tracy T. Batchelor, Kara A. Kittelberger, Ekaterina Tikhonova, Natalia Miheecheva, D Tabakov, Nara Shin, Alisa M. Gorbacheva, Artemy Shumskiy, Felix Frenkel, Estuardo Aguilar-Córdova, Laura K. Aguilar, David Krisky, James Wechuck, Andrea G. Manzanera, Christopher Matheny, Paul P. Tak, Francesca Barone, Daniel Kovarsky, Itay Tirosh, Mario L. Suvà, Kai W. Wucherpfennig, Keith L. Ligon, David A. Reardon, E. Antonio Chiocca - Nature 2023 cited by 256

  5. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 1,031

  6. Therapeutic options for targeting inflammatory osteoarthritis pain

    Authors: , , , - Nature Reviews Rheumatology 2019 cited by 405

  7. Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study

    Authors: , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2018 cited by 287

  8. Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

    Authors: , , , , - Pharmacology & Therapeutics 2007 cited by 1,617

  9. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2012 cited by 470

  10. A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome

    Authors: , , , , , , , , , , , , , , , , , , - JCI Insight 2022 cited by 130

  11. The resolution of inflammation

    Authors: , , , , - Nature reviews. Immunology 2012 cited by 561

  12. A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis

    Authors: , , , , , , , , , , , , - BMJ Open Gastroenterology 2021 cited by 93

  13. Synovial tissue research: a state-of-the-art review

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Rheumatology 2017 cited by 257

  14. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Edward Flynn, Pille Harrison, Lynne J. Hocking, T. Huizinga, Daniel L. Kastner, Xiayi Ke, Annette T. Lee, Xiangdong Liu, Paul Martin, Ann W Morgan, Leonid Padyukov, Marcel D. Posthumus, Timothy R. D. J. Radstake, David M. Reid, Mark Seielstad, Michael F. Seldin, Nancy A. Shadick, Sophia Steer, Paul P. Tak, Wendy Thomson, Annette H M van der Helm–van Mil, Irene E. van der Horst‐Bruinsma, C. Ellen van der Schoot, Piet L. C. M. van Riel, Michael E. Weinblatt, Anthony G. Wilson, Gertjan Wolbink, B P Wordsworth, Cisca Wijmenga, Elizabeth W. Karlson, René E. M. Toes, Niek de Vries, Ann B. Begovich, Jane Worthington, Katherine Siminovitch, Peter K. Gregersen, Lars Klareskog, Robert M. Plenge - Nature Genetics 2010 cited by 1,279

  15. Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis

    Authors: , , , , , , , , , , - Lara D. Veeken 2018 cited by 148

  16. A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis

    Authors: , , , , , , , , , , , - Arthritis Research & Therapy 2021 cited by 89

  17. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages

    Authors: , , , , , , , - Journal of Immunological Methods 2011 cited by 414

  18. Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes

    Authors: , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 cited by 154

  19. Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?

    Authors: , , - Arthritis Research & Therapy 2015 cited by 129

  20. Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2024 cited by 48

  21. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raphael Scarpa, Yeong Wook Song, Enrique R. Soriano, Paul P. Tak, Ilona Újfalussy, Kurt de Vlam, Jessica A. Walsh - Annals of the Rheumatic Diseases 2012 cited by 319

  22. Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2010 cited by 861

  23. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis

    Authors: , , , , , , , , - Annals of the Rheumatic Diseases 2004 cited by 464

  24. Overexpression of toll‐like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll‐like receptor expression in early and longstanding arthritis

    Authors: , , , , , , , , - Arthritis & Rheumatism 2008 cited by 348